Overview Business Model Steering Committee Board of Directors Management

Latest News

TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
2009/12/07

More»  

Excellent Stem Cell Mobilization and Safety Profile for TG-0054
2009/09/28
More»  

TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing
2009/01/20
More»

TaiGen Announces Presentation of Nemonoxacin at the Joint Meeting of ICAAC/IDSA
2008/10/20
More»

TaiGen Announces Positive Data From the Phase II Study of Nemonoxacin (TG-873870) in Community-Acquired Pneumonia
2008/04/07
More»

TaiGen Initiates Phase I Trial of the Stem Cell Mobilizer TG-0054
2008/04/07
More»

Copyright © 2009 TaiGen Biotechnology Co., Ltd.    Contact us     Privacy     Terms of use